Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Bluejay Diagnostics, Inc. - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
BJDX
Nasdaq
3840
bluejaydx.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Bluejay Diagnostics, Inc.
Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering
- Jun 28th, 2024 3:32 pm
Top Midday Decliners
- Jun 27th, 2024 6:00 pm
Bluejay Diagnostics Announces Pricing of $8.75 Million Underwritten Public Offering
- Jun 27th, 2024 12:58 pm
SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients
- Jun 26th, 2024 12:00 pm
Bluejay Diagnostics Announces Reverse Stock Split
- Jun 17th, 2024 12:00 pm
BJDX: 1Q:24 Financial Update
- May 24th, 2024 9:00 am
BJDX: 2023 Financial Update
- Apr 9th, 2024 10:02 am
Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering
- Jan 2nd, 2024 10:58 pm
Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering
- Dec 28th, 2023 1:00 pm
BJDX: SYMON Says: Start the Trial!
- Dec 28th, 2023 9:57 am
Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study)
- Dec 27th, 2023 2:00 pm
Bluejay Diagnostics, Inc. Reports Third Quarter 2023 Financial Results
- Nov 9th, 2023 9:05 pm
BJDX: Toray License Renegotiation
- Nov 8th, 2023 10:22 am
Scroll